SCHEMBL6569434

SCHEMBL6569434

O=C1CC(c2ccccn2)CC(=O)N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 4/20 0.53
DDB1 Q16531 2/20 0.53
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
RAB9A P51151 1/20 0.46
GSK3B P49841 1/20 0.44
HTT P42858 1/20 0.43
PARP16 Q8N5Y8 2/20 0.39
PARP3 Q9Y6F1 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GFER P55789 1/20 0.39
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28357331 0.84 MTNR1A (0.49) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL445499 0.82 MAPT (0.50) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL7568818 0.79 MAPT (0.52) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL27767730 0.79 CRBN (0.71) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL29967570 0.74 CRBN (0.56) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL12533662 0.73 OPRM1 (0.49) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL12533655 0.73 OPRM1 (0.49) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL3392695 0.73 OPRM1 (0.49) CRBNDDB1ALDH1A1KMT2ANPC1
SCHEMBL900225 0.73
SCHEMBL659325 0.73 KDM4E (0.48) CRBNDDB1ALDH1A1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0892790-B1 NEW QUINAZOLINE-4-AMINO-2-(PIPERIDINE-1-YL-4-SUBSTITUTED) DERIVATIVES HAVING ANTI-HYPERTENSIVE ACTIVITY, A METHOD FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE ROTTA RESEARCH LAB (IT) 2004-04-14 EP disclosed
US-5985885-A USEFUL IN THE TREATMENT OF HYPERTENSION, CONGESTIVE HEART FAILURE, PROSTATE HYPERTROPHY, VARIOUS URINARY TRACT DISORDERS AND PATHOLOGICAL SYMPTOMS CAUSED BY HYPERACTIVITY OR DISFUNCTIONING OF THE NORADRENERGIC NEURAL SYSTEM ROTTA RESEARCH LABORATORIUM S.P.A. (IT) 1999-11-16 US disclosed
EP-0892790-A1 NEW QUINAZOLINE-4-AMINO-2-(PIPERIDINE-1-YL-4-SUBSTITUTED) DERIVATIVES HAVING ANTI-HYPERTENSIVE ACTIVITY, A METHOD FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE ROTTA RESEARCH LABORATORIUM S.P.A. (IT) 1999-01-27 EP disclosed
WO-1997037979-A1 NEW QUINAZOLINE-4-AMINO-2-(PIPERIDINE-1-YL-4-SUBSTITUTED) DERIVATIVES HAVING ANTI-HYPERTENSIVE ACTIVITY, A METHOD FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE ROTTA RESEARCH LABORATORIUM S.P.A. (IT) 1997-10-16 WO disclosed